Print

Boehringer Ingelheim Pharmaceuticals, Inc. to Pay $95 Million to Resolve Drug Promo Case  
10/26/2012 6:21:57 AM

Boehringer Ingelheim Pharmaceuticals | Jobs at Boehringer Ingelheim Pharmaceuticals

Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle government claims it improperly promoted four drugs, the U.S. Justice Department said.

The accord ends a federal False Claims Act lawsuit in Maryland filed by Robert Heiden, a former company sales representative, the government said today in a statement. Heiden will get $17 million for his role as whistle-blower.

//-->